首頁 > 市場調查報告書 > 製藥

開發平台分析

市場調查報告書

商品編碼

2077668

組織型胞漿素原原活化劑 (tPA) 市場：按藥物類型、應用和地區分類

Tissue Plasminogen Activator Market, By Drug Type, By Application, By Geography

出版日期: 2026年04月28日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

組織型胞漿素原活化劑（tPA）市場預計在2026年達到30億美元，預計2033年將達到43.4億美元。預計從2026年到2033年，其複合年成長率將達到5.4%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	30億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	5.40%	2033年市場規模預測：	43.4億美元

組織型胞漿素原原活化劑（tPA）是一種參與血栓溶解的酵素。它是絲胺酸蛋白酶。絲胺酸蛋白酶的作用是催化胞漿素原原轉化為胞漿素。絲胺酸蛋白酶是溶解血栓過程中扮演重要角色的關鍵酵素。

市場動態

預計缺血性中風發病率的不斷上升將推動全球組織型胞漿素原原活化劑市場在預測期內的成長。例如，根據健康指標與評估研究所 (IHME) 2019 年的報告，全球整體約有 6,350 萬例缺血性中風病例（95% 置信區間：5,780 萬至 6,900 萬）。 2019 年，全球整體329 萬人死於缺血性中風（297 萬至 354 萬），男性新增病例 345 萬例（296 萬至 403 萬），女性新增病例 419 萬例（361 萬至 491 萬）。

本研究的主要特點：

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數對全球組織型胞漿素原活化劑 (tPA) 市場的主要參與者進行了分析：公司概況、財務績效、產品系列、市場地位、分銷策略、關鍵發展、策略和未來計劃。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
這份「全球胞漿素原活化劑 (tPA) 市場報告」旨在為該行業的各種相關人員提供服務，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用全球組織型胞漿素原活化劑市場分析中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 日本
- 印度
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第7章競爭情勢

熱圖分析
公司簡介
- F. Hoffmann-La Roche AG
- Boehringer Ingelheim GmbH
- CHIESI Farmaceutici SpA
- Gennova Biopharmaceuticals Ltd
- Abbott Laboratories
- Reliance Life Sciences

第8章

參考
調查方法

簡介目錄

Product Code: CMI2469

Tissue Plasminogen Activator Market is estimated to be valued at USD 3.00 Bn in 2026 and is expected to reach USD 4.34 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.4% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 3.00 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	5.40%	2033 Value Projection:	USD 4.34 Bn

Tissue plasminogen activator (tPA) is an enzyme associated with the disintegration of blood clots. It is a serine protease present in endothelial cells. With the help of serine protease, the conversion of plasminogen to plasmin is catalyzed. Serine protease is a major enzyme for clot disintegration.

Market Dynamics

The increasing prevalence of ischemic strokes is expected to drive growth of the global tissue plasminogen activator market over the forecast period. For instance, Institute for Health Metrics and Evaluation report published in 2019, ischemia heart stroke accounted for around 63.5 million (95% UI 57*8-69*0) people globally. Ischemic stroke was responsible for 3.29 million (2*97-3*54) deaths in 2019 globally, with 3.45 million (2*96-4*03) incident cases in males and 4.19 million (3*61-4*91) in females.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global tissue plasminogen activator market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include F. Hoffmann-La Roche AG, Boehringer Ingelheim GmbH, CHIESI Farmaceutici S.p.A., Gennova Biopharmaceuticals Ltd, Abbott Laboratories, and Reliance Life Sciences
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global tissue plasminogen activator market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global tissue plasminogen activator market

Detailed Segmentation:

Global Tissue Plasminogen Activator Market, By Drug Type (Revenue, USD Bn, 2021 - 2033)
Alteplase
Reteplase
Tenecteplase
Global Tissue Plasminogen Activator Market, By Application (Revenue, USD Bn, 2021 - 2033)
Ischemic Stroke
Myocardial Infarction
Pulmonary Embolism
Thrombolysis
Others
Global Tissue Plasminogen Activator Market, By Region (Revenue, USD Bn, 2021 - 2033)
North America
- By Drug Type
  - Alteplase
  - Reteplase
  - Tenecteplase
- By Application
  - Ischemic Stroke
  - Myocardial Infarction
  - Pulmonary Embolism
  - Thrombolysis
  - Others
- By Country
  - U.S.
  - Canada
Latin America
- By Drug Type
  - Alteplase
  - Reteplase
  - Tenecteplase
- By Application
  - Ischemic Stroke
  - Myocardial Infarction
  - Pulmonary Embolism
  - Thrombolysis
  - Others
- By Country
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- By Drug Type
  - Alteplase
  - Reteplase
  - Tenecteplase
- By Application
  - Ischemic Stroke
  - Myocardial Infarction
  - Pulmonary Embolism
  - Thrombolysis
  - Others
- By Country
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- By Drug Type
  - Alteplase
  - Reteplase
  - Tenecteplase
- By Application
  - Ischemic Stroke
  - Myocardial Infarction
  - Pulmonary Embolism
  - Thrombolysis
  - Others
- By Country
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- By Drug Type
  - Alteplase
  - Reteplase
  - Tenecteplase
- By Application
  - Ischemic Stroke
  - Myocardial Infarction
  - Pulmonary Embolism
  - Thrombolysis
  - Others
- By Country
  - GCC
  - Israel
  - Rest of Middle East
Africa
- By Drug Type
  - Alteplase
  - Reteplase
  - Tenecteplase
- By Application
  - Ischemic Stroke
  - Myocardial Infarction
  - Pulmonary Embolism
  - Thrombolysis
  - Others
- By Country/Region
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
F. Hoffmann-La Roche AG *
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
Boehringer Ingelheim GmbH
CHIESI Farmaceutici S.p.A.
Gennova Biopharmaceuticals Ltd
Abbott Laboratories
Reliance Life Sciences

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Application
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trend
Epidemiology
Key Developments
Regulatory Scenario
PEST Analysis
Pipeline Analysis
Acquisition and Collaboration Scenario

4. Global Tissue Plasminogen Activator Market, By Drug Type, 2021 - 2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Alteplase
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
- Segment Trends
Reteplase
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
- Segment Trends
Tenecteplase
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
- Segment Trends

5. Global Tissue Plasminogen Activator Market, By Application, 2021-2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Ischemic Stroke
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
- Segment Trends
Myocardial Infarction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
- Segment Trends
Pulmonary Embolism
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
- Segment Trends
Thrombolysis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Bn)
- Segment Trends

6. Global Tissue Plasminogen Activator Market, By Region, 2021-2033, (US$ Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 -2033, (US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 -2033, (US$ Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 -2033, (US$ Bn)
  - China
  - Japan
  - India
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 -2033, (US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 -2033, (US$ Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 -2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021-2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 -2033, (US$ Bn)
  - North Africa
  - Central Africa
  - South Africa

7. Competitive Landscape

Heat Map Analysis
Company Profiles
- F. Hoffmann-La Roche AG
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Boehringer Ingelheim GmbH
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- CHIESI Farmaceutici S.p.A.
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Gennova Biopharmaceuticals Ltd
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Abbott Laboratories
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies
- Reliance Life Sciences
  - Company Overview
  - Product Portfolio
  - Key Highlights
  - Financial Overview
  - Strategies

8. Section

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

胞漿素原原市場報告：趨勢、預測與競爭分析（至2035年）

胞漿素原原市場－全球產業規模、佔有率、趨勢、機會、預測：按類型、應用、地區和競爭格局分類，2021-2031年

胞漿素原：全球市場佔有率和排名、總收入和需求預測（2025-2031年）

FAQ

組織型胞漿素原原活化劑 (tPA) 市場：按藥物類型、應用和地區分類